
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding a press release dated May 21, 2021, titled "Balaxi Pharmaceuticals reports a PAT of INR 381 million for FY21; further strengthens the Product Pipeline ".
Filed with NSE ·

BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding a press release dated May 21, 2021, titled "Balaxi Pharmaceuticals reports a PAT of INR 381 million for FY21; further strengthens the Product Pipeline ".
6ix hasn’t read this filing yet.
Balaxi Pharmaceuticals Limited on 6ix
Follow Balaxi Pharmaceuticals into a list and get an email when it puts out news.
Follow Balaxi Pharmaceuticals